Effects of antiplatelet agents on platelet-induced thrombin generation

International Journal of Clinical Pharmacology and Therapeutics

Volumn 40, Issue 4, 2002, Pages 135-141

  Wegert, W ^a   Graff, J ^a   Kaiser, D ^a   Breddin, H K ^a   Klinkhardt, U ^a   Harder, S ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Abciximab; Aspirin; Clopidogrel; Thrombin generation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; AMINO ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; COLLAGEN; FIBRINOGEN RECEPTOR ANTAGONIST; PURINERGIC RECEPTOR BLOCKING AGENT; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOPLASTIN; THROMBOXANE SYNTHASE INHIBITOR;

ADULT; AMINO ACID SEQUENCE; ARTICLE; AUTOMATION; BLEEDING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ASSAY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; NORMAL HUMAN; PHARMACODYNAMICS; REPRODUCIBILITY; RISK FACTOR; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

EID: 0036213482     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40135     Document Type: Article

References (28)

1. Effect of sodium arachidonate on thrombin generation through platelet activation - Inhibitory effect of aspirin
2. In vivo demonstration of an antithrombin effect of abciximab
3. Platelets and proteases
4. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets
5. Antiplatelet agents in tissue-factor induced blood coagulation
6. Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention
7. ADP receptors of platelets and their inhibition
8. Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM 337) in healthy subjects
9. In vitro dose response to different GPIIb/IIIa-antagonists: Interlaboratory comparison of various platelet function tests
10. The thrombogram: Monitoring thrombin generation in platelet-rich plasma
11. Continuous registration of thrombin generation in plasma. Its use for determination of the thrombin potential
12. Thrombin generation in plasma: Its assessment via the endogenous thrombin potential
13. Endogenous thrombin potential
14. Measurement of thrombin generation in whole blood. The effect of heparin and aspirin
15. Treatment with a GPIIb/IIIa-antagonist inhibit thrombin generation in platelet-rich plasma from patients
16. The effect of active-site inhibited factor VIIa on tissue factor initiated coagulation using platelets before and after aspirin administration
17. Ex vivo - In vitro interaction between ASA, clopidogrel and the GPIIb/IIIa-inihibitors abciximab and SR121566A
18. Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis of major clinical trials
19. Transmission of a procoagulant signal from tissue factor-bearing cells to platelets
20. Circulating tissue factor and thrombosis
21. Identification and biological activity of the active metabolite of clopidogrel
22. 12, a new platelet ADP receptor, target of clopidogrel
23. Antiplatelet agents in cardiology: The choice of therapy
24. The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity
25. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides
26. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: Bleeding, reversal, thrombocytopenia, and retreatment
27. Influence of low-and high-dose aspirin treatment on thrombin generation in whole blood